Some of its targets, notably VEGF (Vascular Endothelial Growth Factor), EPO (Erythropoietin) and IGF2 (Insulin Like Growth Factor 2), have been implicated in tumor-induced angiogenesis1,9. The gene discussed is EPO; the disease is neoplasm.